Tekfen Ventures appeared to be the VC, which was created in 2016. The main department of described VC is located in the New York. The venture was found in North America in United States.
The common things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2018. The typical startup value when the investment from Tekfen Ventures is 100-500 millions dollars.
Besides them, we counted 2 critical employees of this fund in our database.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Agriculture, Internet of Things. Among the most popular portfolio startups of the fund, we may highlight Sight Machine, Pivot Bio, Claroty. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 1 of the founder, the chance for it to get the investment is meager.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Tekfen Ventures, startups are often financed by Bessemer Venture Partners, Orfin Ventures, Oreilly AlphaTech Ventures. The meaningful sponsors for the fund in investment in the same round are Yamaha Motor Ventures & Laboratory Silicon Valley, Material Impact Fund, Hyperplane Venture Capital. In the next rounds fund is usually obtained by Sony Innovation Fund, Oreilly AlphaTech Ventures, Mercury Fund.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Albany Molecular Research | Albany, New York, United States |
| Bluefield Investments | England, London, United Kingdom |
| Branding Engineer | Japan, Kanagawa Prefecture, Yamato |
| China Resources Pharmaceutical Group | China, Hong Kong, Hong Kong Island |
| Chongqing Gaoxin Jishu Chanye Kaifaqu Chuangxin Fuwu Zhongxin | China, Chongqing, Chongqing Shi |
| Fusheng Group | - |
| Fuyu (Shanghai) Investment Management | - |
| KB 1 Capital India | - |
| LatAm Startups | Canada, Ontario, Toronto |
| Lorimer Ventures | Brooklyn, New York, United States |
| NGI Capital | - |
| Ontario | Canada, Ontario, Toronto |
| ORR Partners | Reston, United States, Virginia |
| PacifiCap | Oregon, Portland, United States |
| PeopleSoft | California, Pleasanton, United States |
| Ping An Bank | China, Guangdong Province, Huizhou |
| Sunstone Life Science Ventures | Copenhagen, Denmark, Hovedstaden |
| The Difference Engine | Cumbria, England, United Kingdom |
| United Investments | New Taipei, Taiwan |
| Zhangshushi Qianpeng Touzi Guanli Zhongxin | China, Jiangxi, Yichun |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Laverock Therapeutics | $18M | 28 Sep 2023 | - | ||
Tropic Biosciences | $35M | 06 Jul 2022 | London, England, United Kingdom | ||
Mosaic | $44M | 01 Nov 2021 | Phoenix, Arizona, United States | ||
Soft Robotics | $10M | 29 Jun 2021 | Massachusetts, United States | ||
Avvir | $10M | 26 Mar 2021 | New York, New York, United States | ||
Phospholutions | $10M | 26 Jan 2021 | State College, Pennsylvania, United States | ||
| $28M | 04 Jun 2020 | London, England, United Kingdom | |||
Pivot Bio | $100M | 30 Apr 2020 | Berkeley, California, United States | ||
Soft Robotics | $22M | 17 Jan 2020 | Massachusetts, United States |
– Pivot Bio, a Berkeley, CA-based nitrogen innovator in agriculture, closed a $430m Series D funding.
– The round was led by DCVC and Temasek with participation from Generation Investment Management, G2 Venture Partners, Rockefeller Capital Management, Breakthrough Energy Ventures, Continental Grain Company, Prelude Ventures; Pavilion Capital, Bunge Ventures, Tekfen Ventures, and Roger Underwood.
– The company intends to use the funds to focus on scaling its U.S. business and expanding into key international markets.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Laverock Therapeutics | $18M | 28 Sep 2023 | - | ||
Tropic Biosciences | $35M | 06 Jul 2022 | London, England, United Kingdom | ||
Mosaic | $44M | 01 Nov 2021 | Phoenix, Arizona, United States | ||
Soft Robotics | $10M | 29 Jun 2021 | Massachusetts, United States | ||
Avvir | $10M | 26 Mar 2021 | New York, New York, United States | ||
Phospholutions | $10M | 26 Jan 2021 | State College, Pennsylvania, United States | ||
| $28M | 04 Jun 2020 | London, England, United Kingdom | |||
Pivot Bio | $100M | 30 Apr 2020 | Berkeley, California, United States | ||
Soft Robotics | $22M | 17 Jan 2020 | Massachusetts, United States |
